アミノグリコシドによるメタボライト活性化によるバクテリアの根絶が持続する
Kyle R Allison1, Mark P Brynildsen, James J Collins
1Howard Hughes Medical Institute, Department of Biomedical Engineering, Center for Biodynamics and Center for Advanced Biotechnology, Boston University, Boston, Massachusetts 02215, USA.
Nature
|May 13, 2011
まとめ
特定の代謝刺激は,抗生物質に耐性のある不活性なバクテリアのペリシスターを殺すことができます. このアプローチは,グラム陰性およびグラム陽性細菌に対するアミノグリコシドの有効性を高め,慢性感染症の治療に役立ちます.
科学分野:
- 微生物学 微生物学とは
- バクテリアの生理学
- 抗生物質耐性菌は,抗生物質耐性菌である.
背景:
- 細菌の持続性菌は,抗生物質に耐性のある休眠細胞であり,慢性および再発性感染症に寄与します.
- 現在の治療法は,持続性のある細胞を根絶するための効果的な手段を欠いている.
- 持続性菌は,持続的な細菌感染症の治療における重要な課題です.
研究 の 目的:
- 抗生物質耐性細菌の持続性を根絶するための代謝戦略を調査する.
- 代謝刺激がアミノグリコシドの効能を強めるかどうかを判断する.
- バイオフィルムと慢性感染症の治療におけるこのアプローチの可能性を調査する.
主な方法:
- グラム陰性菌 (Escherichia coli) とグラム陽性菌 (Staphylococcus aureus) の治療は,アミノグリコシドおよび特定の代謝刺激剤を用いて継続されます.
- 成長再開にかかわらず,有酸素および無酸素条件下で殺す有効性の評価.
- 陽子運動力とアミノグリコシドの吸収を含むメカニズムの調査.
- マウスの尿路感染症モデルで組み合わせ治療を試験する.
主要な成果:
- 特定の代謝刺激により,E. coliとS. aureusの両方のアミノグリコシドによる殺戮が強化され,持続します.
- 強化はアミノグリコシド特異的であり,成長再開を必要とせず,さまざまな条件で効果がありました.
- そのメカニズムは,陽子運動力を発生させ,アミノグリコシドの吸収を高めることでした.
- コンビネーションセラピーは,E. coliとS. aureusのバイオフィルムを効果的に治療し,マウス感染モデルでのアウトカムを改善しました.
結論:
- 代謝刺激は,抗生物質耐性を克服し,バクテリアの持続性を根絶する実行可能な戦略を提供します.
- バクテリアの代謝をターゲットにすることで,アミノグリコシドのような既存の抗生物質の有効性を高めることができます.
- このアプローチは,困難な持続性感染症とバイオフィルムの治療に有望である.
関連する概念動画
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:28Microbial Bioremediation of Pesticides
Pesticides often feature structurally complex chemical architectures, incorporating halogen groups and multiple aromatic rings. These characteristics confer high chemical stability, rendering many pesticides resistant to natural degradation processes. This resistance poses significant environmental concerns, as persistent pesticide residues can accumulate in ecosystems and affect non-target organisms.Despite the inherent stability of many pesticides, certain microorganisms possess the metabolic...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...